baber/WOPTO huggingface dataset:
Patent NZ-579673-A (NZ)
Title: Brassica oleracea plants with a resistance to albugo candida
Inventor: GEUS DE JAN
IPC: C12Q1/68
Filed: 2008-04-22
Abstract: Disclosed is a Brassica oleracea plant, comprising a dominant resistance gene to Albugo candida, the cause of white blister, said resistance gene comes from the B. oleracea plant, the seeds of which were deposited on 1 March 2006 in the American Type Culture Collection (ATCC, Patent Depository, 10801 University Boulevard, Manassas, VA 20110, United States of America) under number PTA 74-12, wherein the presence of an introgression with the resistance gene is demonstrated using at least two specific DNA markers chosen from table 1 linked to the resistance gene and wherein the presence of the DNA markers in the genome of the plant is demonstrated using primer sequences chosen from the group consisting of SEQ ID NO: 1 up to and including SEQ ID NO: 10 as defined in table 2.
Patent NZ-581536-A (NZ)
Title: Auxiliary device for disassembly/assembly of a tunnel thruster
Inventor: ANDERSSON LARS-GORAN
IPC: B63H5/16
Filed: 2005-04-12
Abstract: An auxiliary device 1 for dismantling a tunnel thruster unit 2 inside the tunnel 4 comprises a rigid construction 10 with transport members 11A, 11B and at least one guiding member 14B. The guiding member 14B comprises a contact part arranged to guide movement of the auxiliary device 1 within the tunnel 4.
Patent NZ-583780-A (NZ)
Title: Methods for treating osteoarthritis pain by administering a nerve growth factor antagonist and compositions containing the same
Inventor: ROSENTHAL ARNON
IPC: A61P29/02
Filed: 2006-04-11
Abstract: Provided is the use of an effective amount of an NGF antagonist in the preparation or manufacture of a medicament for improving stiffness in an individual having osteoarthritis, wherein the NGF antagonist is an anti-NGF antibody. Various dosages and specified heavy and light chain variable regions comprising specified sequences of CDR1, CDR2 and CDR3 are also provided, as well as corresponding kits.
Patent NZ-586510-A (NZ)
Title: Tapered helical auger turbine to convert hydrokinetic energy into electrical energy
Inventor: ANDERSON WINFIELD SCOTT JR
IPC: F03B3/12
Filed: 2009-09-25
Abstract: 586510 A helical auger turbine (10) is disclosed. The turbine (10) comprises a generally helical turbine blade (11) rotatably mounted on a central shaft (14). A flange (12) extends perpendicularly from an edge of the turbine blade (11) having a width approximately 25% of a diameter of turbine blade (11). At least one turbine blade support connection (16) connects the central shaft (14) to a support structure. The turbine can be used in a hydrokinetic device such as a tidal power generator to operate a pressure pump for generating electricity from water currents.
Patent NZ-590453-A (NZ)
Title: Using a start of frame delimiter following a header with a preamble to identify a data rate of a packet
Inventor: BORLESKE ANDREW J
IPC: H04L12/44
Filed: 2011-01-12
Abstract: A wireless mesh network and a method of operating a wireless network is disclosed. The wireless mesh network comprises a central node and a plurality of bi-directional nodes. The central node comprises a transceiver configured to transmit and receive data communications using selected frequency channels of a plurality of frequency channels. The plurality of bidirectional nodes are in bidirectional wireless communication with the central node, where each bidirectional node has a respective wireless communication path to the central node that is either a direct path or an indirect path through one or more intermediate bidirectional nodes serving as repeater nodes. The central node initiates a data communication from the central node to a particular bidirectional node of the plurality of bidirectional nodes. The data communication comprises a synchronization header comprising a preamble waveform and a start-of-frame delimiter (SFD) token value that identifies an end of the synchronization header and a start of packet data, and which identifies a data rate selected from a plurality of data rates.
Patent NZ-590782-A (NZ)
Title: 6-Amino-2-{ [(1S)-1-methylbutyl]oxy} -9-[5-(piperidin-1-yl)pentyl]-7,9-dihydro-8H-purin-8-one and pharmaceutical uses thereof
Inventor: BIGGADIKE KEITH
IPC: A61K31/522
Filed: 2009-08-07
Abstract: Disclosed is the compound 6-amino-2-{ [(1S)-1-methylbutyl]oxy} -9-[5-(1-piperidinyl)pentyl]-7,9-dihydro-8H-purin-8-one, or a salt thereof. Further disclosed is a pharmaceutical composition which comprising a compound as defined above, and one or more pharmaceutically acceptable diluents or carriers, and which may optionally be formulated for intranasal or inhaled administration, for the treatment of allergic diseases and other inflammatory conditions (including allergic rhinitis and asthma), infectious diseases, and cancer.
Patent NZ-591925-A (NZ)
Title: Adjuvant composition comprising a host defense peptide, an immunostimulatory sequence and a polyanionic polymer
Inventor: VAN DRUNEN LITTEL-VAN DEN HURK SYLVIA
IPC: A61K39/10
Filed: 2009-10-15
Abstract: Methods and compositions for enhancing an immune response to a selected antigen are described. The methods are useful for the treatment and prevention of microbial infections, such as infections caused by bacteria, viruses, fungi and parasites. The methods and compositions include host defense peptides, polyphosphazenes and immunostimulatory sequences to enhance the immune response to a coadministered antigen.
Patent NZ-592663-A (NZ)
Title: Skin treatments containing carboxylic acid-substituted idebenone derivatives and methods of preparation and use thereof
Inventor: DIEDRICH FALKO
IPC: A61Q19/02
Filed: 2009-10-06
Abstract: Disclosed is a carboxylic acid functionalised sugar attached to a idebenone moiety of formula (I). Also disclosed is a method of preparing a compound of formula (I), a composition comprising a compound of formula(I) and the use of a compound of formula (I) for the manufacture of a medicament for treating a skin change such as UV damage, skin aging, cellulitis and erythematous.
Patent NZ-593628-A (NZ)
Title: Genetic variants useful for risk assessment of thyroid cancer using rs944289
Inventor: GUDMUNDSSON JULIUS
IPC: A61K31/7088
Filed: 2009-11-26
Abstract: Patent No. 593628 Disclosed is a method for determining a susceptibility to thyroid cancer in a human individual, comprising determining whether at least one allele of at least one polymorphic marker is present in a nucleic acid sample obtained from the individual, or in a genotype dataset derived from the individual, wherein at least one polymorphic marker is selected from the group consisting of rs944289 and markers in linkage disequilibrium therewith.
Patent NZ-593878-A (NZ)
Title: Printed medium support incorporating a usb unit holder and related method
Inventor: ANDRE OLIVIER
IPC: G06K19/00
Filed: 2009-05-06
Abstract: 593878 Disclosed is a printed medium (400) which incorporates a separable USB unit holder (300). The USB unit holder houses a USB unit and comprises a main body made of cardboard. The USB unit holder is retained within an opening (422) of the printed medium, with frangible portions (430) connecting the USB unit holder to the edge that surrounds the opening. A printed medium might include a catalog, a brochure, a leaflet, a magazine, a book, a manual or the like. A method of providing users with information identifying a commercial product or service promoting the aforementioned product or service is also disclosed.
Patent NZ-595873-A (NZ)
Title: Anti-slip stocking sole with grip members on the bottom surface comprising beading
Inventor: BURMEISTER DIANNE
IPC: A61F13/08
Filed: 2010-11-01
Abstract: Disclosed is a compression stocking comprising a foot portion for covering at least portion of a wearer's foot. The foot portion includes a toe region (13) and a heel region (14) and a sole (15) extending between the toe region and heel region, the sole having a bottom surface (20) for contacting a floor. The foot portion has anti-slip means comprising beading (22) forming one or more grip members (21) disposed on the bottom surface of the sole.
Patent NZ-599431-A (NZ)
Title: Human anti-ngf neutralizing antibodies as selective ngf pathway inhibitors
Inventor: WILD KENNETH D
IPC: G01N33/53
Filed: 2010-10-08
Abstract: Disclosed is the use of an NGF antibody (4D4) in the manufacture of a medicament for treating a condition caused by increased expression of NGF or increased sensitivity to NGF, - wherein the NGF antibody comprises a light chain comprising SEQ ID. NO. 44 and a heavy chain comprising SEQ ID. NO. 40 as defined in the complete specification; - wherein the NGF antibody dose is selected from the group consisting of 3 mg, 10 mg, and 20 mg; - wherein the medicament is for use orally, through injection by intravenous, intraperitoneal, intracerebral, intra-parenchymal, intracerebroventricular, intramuscular, intra-ocular, intraarterial, intraportal, intralesional or subcutaneous routes, by sustained release systems, or by implantation devices; and - wherein the condition is osteoarthritis (OA) knee pain, acute pain, dental pain, pain from trauma, surgical pain, pain resulting from amputation or abscess, causalgia, demyelinating diseases, trigeminal neuralgia, cancer, chronic alcoholism, stroke, thalamic pain syndrome, diabetes, acquired immune deficiency syndrome (”AIDS”), toxins, chemotherapy, general headache, migraine, cluster headache, mixed-vascular or non-vascular syndromes, tension headache, general inflammation, arthritis, rheumatic diseases, lupus, osteoarthritis, fibromyalgia, inflammatory bowel disorders, irritable bowel syndrome, inflammatory eye disorders, inflammatory or unstable bladder disorders, psoriasis, skin complaints with inflammatory components, sunburn, carditis, dermatitis, myositis, neuritis, collagen vascular diseases, chronic inflammatory conditions, inflammatory pain and associated hyperalgesia and allodynia, neuropathic pain and associated hyperalgesia or allodynia, diabetic neuropathy pain, sympathetically maintained pain, deafferentation syndromes, asthma, epithelial tissue damage or dysfunction, herpes simplex, disturbances of visceral motility at respiratory, genitourinary, gastrointestinal or vascular regions, wounds, burns, allergic skin reactions, pruritis, vitiligo, general gastrointestinal disorders, colitis, gastric ulceration, duodenal ulcers, vasomotor or allergic rhinitis, or bronchial disorders, dysmenorrhoea, dyspepsia, gastroesophageal reflux, pancreatitis, or visceralgia.
Patent NZ-604011-A (NZ)
Title: Crystalline forms of thalidomide and processes for their preparation
Inventor: MEKDE SANDEEP
IPC: C07D401/04
Filed: 2011-06-09
Abstract: Disclosed is a process for preparing an anhydrous, crystalline alpha form of thalidomide, comprising cyclising N-phthaloyl-glutamine (optionally in the presence of a coupling agent and/or catalyst) in an organic solvent system and isolating the anhydrous, crystalline alpha-form of thalidomide, wherein the organic solvent system comprises a solvent selected from the group comprising straight chain or branched aliphatic ketones (such as acetone, butanone or mixtures thereof), aliphatic nitriles (such as acetonitrile, propionitrile or mixtures thereof), ethers (such as tetrahydrofuran (THF), tertiary butyl methyl ether (TBME) or mixtures thereof) and mixtures thereof, wherein the reaction mixture is heated to a temperature (optionally at reflux) between about 50°C and about 100°C, and wherein the reaction mixture is further cooled in order to isolate the anhydrous, crystalline alpha form of thalidomide, wherein the X-ray diffractogram of the anhydrous alpha form of thalidomide contains characteristic peaks at about 11.30, 14.29, 19.15, 22.82, 26.10 and 30.32 ±0.2 degrees 2-theta. Also disclosed is a process for preparing crystalline form alpha of thalidomide, comprising dissolving thalidomide in dimethylsulfoxide (DMSO), adding the mixture to methanol containing suspended seed crystals of the alpha form of thalidomide, and isolating the pure, anhydrous, crystalline c-form of thalidomide, wherein the X-ray diffractogram of the anhydrous alpha form of thalidomide contains characteristic peaks at about 11.30, 14.29, 19.15, 22.82, 26.10 and 30.32 ±0.2 degrees 2-theta.
Patent NZ-616627-A (NZ)
Title: A multidimensional system for monitoring and tracking states and conditions
Inventor: LAHYANI IRIS
IPC: G01C23/00
Filed: 2011-03-28
Abstract: Disclosed is a monitoring system for monitoring motion of a body. The system comprises a set of sensors and a processor. The set of sensors comprises ne or more orientation or three-dimensional position sensors mounted, or in a relation to, a body. The set of sensors measures three-dimensional position and orientation parameters as a function of time to generate an indication of a change in displacement, velocity or acceleration in any desired dimension. The processor processes measurement results of the set of sensors and determines when the measurement results are indicative of an abnormal body state. The monitoring system is continuously operable after indication of the abnormal body state such that the processor initiates a severity level assessing mode by which the measurement results are compared at a first time being defined as a time when the abnormal state was determined to the measurement results at a second time subsequent to the first time at which the orientation of the body with respect to a vertical plane changed from the orientation of the body at the first time. The monitoring system output a determined severity level of the abnormal state and initiates an action in response to the determined severity level.
Patent NZ-617805-A (NZ)
Title: Polysiloxane-based fouling release coats including enzymes
Inventor: OLSEN STEFAN MØLLER
IPC: C09D7/45
Filed: 2012-06-29
Abstract: Disclosed herein are polysiloxane based fouling release coatings comprising a polysiloxane-based binder matrix from a polysiloxane based binder which is a functional organopolysiloxane with terminal and/or pendant functionality, said polysiloxane-based binder matrix constituting 50-90 % by dry weight of the coat, one or more enzymes and one or more hydrophilic-modified polysiloxane oils in an amount of 0.05-10 % by dry weight of the coat.
Patent NZ-621411-A (NZ)
Title: Apparatus for bridges
Inventor: WHEELER TROY
IPC: E04G3/24
Filed: 2012-11-19
Abstract: Disclosed is a bridge maintenance personnel platform for use on a bridge so that the counterweight is contained within a secondary passageway such as a walkway or cycle lane and does not extend out into the vehicle lanes so traffic flows remain unimpeded. The bridge has an upper load surface and at least one peripheral edge. The platform apparatus includes a platform for suspension beyond the peripheral edge of the bridge and a counterweight for placement on the bridge adjacent said peripheral edge. A rigid connector, rigidly connects the platform and counterweight together and extends between the platform and counterweight. The counterweight placement on the bridge surface is static and excludes placement on any mobile mechanism or platform such as a vehicle, wheels, tracks or the like. The counterweight is configured to fit solely within the secondary passageway to avoid extending onto the primary transport passageway and disrupting traffic thereon and the counterweight incorporates a walkway permitting passage through the counterweight. The connector and/or the connections to the counterweight and platform are unarticulated.
Patent NZ-622189-A (NZ)
Title: Transformation method of hybrid transportation vehicle for ground and air, and hybrid transportation vehicle itself
Inventor: KLEIN ŠTEFAN
IPC: B64C37/00
Filed: 2012-08-22
Abstract: Transformation method of hybrid transportation vehicle for ground and air includes the following transformation and reciprocal steps: Tilting the compensation cover (7) on. Expansion of both whole wings (1) from the transportation vehicle longitudinal position around two vertical axes into the flying position. Expansion of rear parts of wings from the top front parts of wings into the spread flying position by tilting the rear of each wing around a horizontal axis. The take-off and landing tilting of wings by an angle of attack alpha = 0 to 40° of the wings onset. Front wheels track is reduced by axially shifting the front wheels towards the fuselage. Furthermore, a corresponding hybrid transportation vehicle for ground and air is described which contains reciprocal transformation mechanisms for transformation from a sterling double or four-track automobile into a sterling aircraft for take-off and landing on the ground or water, and vice versa.
Patent NZ-630512-A (NZ)
Title: Cap assembly for a beverage container
Inventor: JEFFERY SILVER TAGGART
IPC: B67D1/12
Filed: 2014-03-28
Abstract: Disclosed is a cap assembly for sealing a beverage container for holding a gas entrained beverage, the cap assembly cooperates with a dispensing assembly to dispense the beverage. A problem which can occur in filling and sealing the container assembly is that after the container is filled with carbonated beverage and the dip tube or siphon tube in the cap assembly is inserted into the container, air or other gases can become trapped in the dispensing path between an upper level of the beverage in the dip tube or siphon tube and the flow valve, causing excess foam head or reduced beverage quality. The cap assembly includes a first cap component; and a beverage outlet port including a normally-closed beverage dispensing valve and a beverage outlet aperture for dispensing beverage therethrough when the beverage dispensing valve is opened, the beverage outlet aperture being formed in the first cap component. The first cap component is provided with a cap cover for reducing ingress of contaminants into the cap assembly, and wherein the cap cover includes an access aperture positioned or positionable over the beverage outlet aperture such that the beverage dispensing valve is openable from outside the cap assembly without removing or breaching the cap cover. A second cap component is fastened or housed to the first cap component. A gas cartridge provides a gas source.
Patent NZ-708034-A (NZ)
Title: Eccentric screw pump
Inventor: KRAMPE PAUL
IPC: F04C2/107
Filed: 2015-05-12
Abstract: An eccentric screw pump, comprising a rotor (70) that extends along a longitudinal axis (1) of the rotor from a drive end to a free end, a stator housing (90) with an internal cavity that extends along the longitudinal axis (1) from a stator inlet opening (90a) to a stator outlet opening (90b) and that is designed to accommodate the rotor (70), a drive motor (60) with a drive shaft that is coupled with the rotor (70) to transmit a torque, a first cardan joint (22) which is placed within the transmission of the torque between the drive shaft and the rotor, and a stator outlet flange (100) that is arranged in flow direction behind the rotor (70). The stator outlet flange (100) comprises a flange connection plane (100‘) that is oriented non-vertically to the longitudinal axis. The stator outlet flange is arranged such that the rotor is insertable into the stator through the stator outlet flange. The aim of the invention is to provide easy access to components for tasks such as maintenance or cleaning.
Patent NZ-718569-A (NZ)
Title: Well treatment fluids containing a zirconium crosslinker and methods of using the same
Inventor: GUPTA D V SATYANARAYANA
IPC: C09K8/68
Filed: 2014-08-27
Abstract: A fracturing fluid containing a hydratable viscosifying polymer and a zirconium acetylacetonate crosslinker provides a green alternative to conventional systems. The zirconium aceylacetonate is dissolved in benzyl alcohol or in a mixture of benzyl alcohol and 2,2-dimethyl-l,3-dioxolan-4(yl)-methanol. The pH of the fracturing fluid may be between from about 3.5 to about 11.5. The fracturing fluid may contain an acidic buffering agent or a basic buffering agent. The fracturing fluid may be pumped into a well in order to initiate or enlarge a fracture within a subterranean formation penetrated by the well.
Patent NZ-727475-A (NZ)
Title: Aryl receptor modulators and methods of making and using the same
Inventor: BELLINVIA SALVATORE
IPC: C07D471/04
Filed: 2015-06-26
Abstract: The present invention is generally directed towards compounds capable of binding the aryl hydrocarbon receptor and modulating its activity,methods of treating inflammatory conditions such as Crohn’s disease using such compounds, and pharmaceutical compositions comprising such compounds. Also provided are methods of increasing levels of IL-22 in a subject and/or decreasing levels of IFN-γ in a subject.
Patent NZ-742764-A (NZ)
Title: Pipe element having wedging groove
Inventor: MADARA SCOTT
IPC: F16L21/06
Filed: 2017-01-19
Abstract: A pipe element has a circumferential groove with a surface portion oriented at an angle with respect to its longitudinal axis. A surface portion of the groove adjacent to the angled surface portion is oriented perpendicular to the longitudinal axis. A mechanical coupling has projecting keys that engage the groove. The keys have mating surfaces that contact both the perpendicular and angled surface portions of the groove. When the pipe element and coupling are used in combination to form a pipe joint, axial load on the pipe, resisted by the mechanical coupling, is shared between the perpendicular and angled surface portions which results in a pipe joint that can withstand higher internal pressure than if the axial load were borne by the perpendicular surface portion alone. The pipe element of the present invention aims to overcome the limitations of the prior art. Such limitations include, for example, the need to weld rings onto the pipe elements. An improvement of the pipe element strength is desirable to improve pressure performance and axial tensile loading limits.
Patent NZ-748364-A (NZ)
Title: A method of filling feeding pans as well as a feeding system
Inventor: ANDERSEN KARSTEN EGELUND
IPC: A01K39/012
Filed: 2017-04-25
Abstract: A feeding system for freely moving poultry or other small animals, comprising a feeding pan (1) having an outer distribution cone (7), wherein an overlying horizontal transport channel (5) for feed is provided above the distribution cone (7), wherein a passage for regular feeding (10) out of the transport channel (5) is provided, and wherein the feed, when passing there through, passes through the opening (11) at the top of the distribution cone (7) to the inner side of the distribution cone (7). Advantageously, and prior to the passage for regular feeding (10) in the direction of movement of the feed, there is a passage for initial feeding (9) out of the transport channel (5), arranged such that the feed passes out of the initial feeding passage and impinges on separate chutes (14) externally on the distribution cone (7), a dividing line between the two chutes (14) being provided in the distribution cone (7). The channel is rotated to permit regular or initial feeding
Patent NZ-748469-A (NZ)
Title: Synchronous waveform clock synchronization without a system controller
Inventor: Vachula George
IPC: H04L12/54
Filed: 2017-04-07
Abstract: A method for synchronizing a time reference of a terminal clock of a terminal transceiver including an antenna and a modem, the method including: transmitting, by the modem, a terminal sync hop to a signal relay in accordance with the time reference; searching, by the modem, for a terminal sync hop return from the signal relay near an estimated terminal sync hop receive time; receiving, by the modem, the terminal sync hop return at a terminal sync hop receive time; searching, by the modem, for a master sync hop return from the signal relay; receiving, by the modem, the master sync hop return at a master sync hop receive time; calculating, by the modem, a time difference between the master sync hop receive time and the terminal sync hop receive time; and adjusting, by the modem, the time reference based on the calculated time difference.